HGXVX
Price
$16.47
Change
-$0.08 (-0.48%)
Updated
Jun 25 closing price
Net Assets
287.05M
RSLBX
Price
$59.86
Change
-$0.17 (-0.28%)
Updated
Jun 25 closing price
Net Assets
77.12B
Interact to see
Advertisement

HGXVX vs RSLBX

Header iconHGXVX vs RSLBX Comparison
Open Charts HGXVX vs RSLBXBanner chart's image
Hartford Global Impact R6
Price$16.47
Change-$0.08 (-0.48%)
VolumeN/A
Net Assets287.05M
American Funds SMALLCAP World R2
Price$59.86
Change-$0.17 (-0.28%)
VolumeN/A
Net Assets77.12B
HGXVX vs RSLBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HGXVX vs. RSLBX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGXVX is a StrongBuy and RSLBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLBX has more cash in the bank: 77.1B vs. HGXVX (287M). HGXVX pays higher dividends than RSLBX: HGXVX (1.12) vs RSLBX (0.02). HGXVX was incepted earlier than RSLBX: HGXVX (8 years) vs RSLBX (23 years). RSLBX (1.75) is less costly to investors than HGXVX (0.75). HGXVX is a more actively managed with annual turnover of: 36.00 vs. RSLBX (32.00). HGXVX has a lower initial minimum investment than RSLBX: HGXVX (0) vs RSLBX (250). HGXVX annual gain was more profitable for investors over the last year : 13.91 vs. RSLBX (6.88). HGXVX return over 5 years is better than : 59.45 vs. RSLBX (15.38).
HGXVXRSLBXHGXVX / RSLBX
Total Expense Ratio0.691.7539%
Annual Report Gross Expense Ratio0.751.7543%
Fund Existence8 years23 years-
Gain YTD8.5965.024171%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets287M77.1B0%
Annual Yield % from dividends1.120.025,986%
Returns for 1 year13.916.88202%
Returns for 3 years36.7825.18146%
Returns for 5 years59.4515.38386%
Returns for 10 yearsN/A25.76-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGMO0.580.07
+13.27%
Sangamo Therapeutics
RPRX35.91-0.23
-0.64%
Royalty Pharma plc
CYCN2.97-0.03
-0.84%
Cyclerion Therapeutics
ABM44.45-0.59
-1.31%
ABM Industries
HTLD8.66-0.15
-1.65%
Heartland Express